Monoclonal antibody therapy in cancer: When two is better (and considerably more expensive) than one

Journal of Clinical Pharmacy and Therapeutics, EarlyView.

Source: Journal of Clinical Pharmacy and Therapeutics - July 26, 2018 Category: Drugs & Pharmacology Authors: Gregory M. Peterson PhD , Jackson Thomas PhD , Kwang C. Yee PhD , Sam Kosari PhD , Mark Naunton PhD , Inger H. Olesen MBBS (Hons), FRACP Source Type: research